Raymond James Reaffirms “Outperform” Rating for Knight Therapeutics (TSE:GUD)  Sundance Herald

Knight Therapeutics (TSE:GUD)’s stock had its “outperform” rating reaffirmed by equities research analysts at Raymond James in a research note issued on …